Latest Ratios: P/E Ratio 90.4x · EV/EBITDA 15.7x · ROE 4.1%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $244M | $255M | $542M | $610M | $692M | $615M | $274M | $513M | $355M | $260M | $245M |
| Enterprise Value | $221M | $231M | $500M | $587M | $656M | $600M | $284M | $524M | $390M | $297M | $273M |
| P/E Ratio → | 90.38 | 81.50 | 23.14 | 34.41 | 37.46 | 45.28 | — | — | — | — | 34.55 |
| P/S Ratio | 0.92 | 0.96 | 1.89 | 2.18 | 2.63 | 2.74 | 1.38 | 2.28 | 1.69 | 1.40 | 1.22 |
| P/B Ratio | 4.23 | 3.82 | 6.52 | 7.76 | 8.36 | 7.70 | 4.61 | 6.26 | 4.40 | 3.05 | 2.61 |
| P/FCF | 20.22 | 21.12 | 9.59 | 27.50 | 14.76 | 14.61 | 14.99 | 21.73 | 48.33 | 87.95 | 9.26 |
| P/OCF | 8.44 | 8.81 | 9.00 | 17.07 | 13.25 | 13.31 | 9.95 | 16.85 | 21.03 | 14.97 | 7.50 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.87 | 1.74 | 2.09 | 2.50 | 2.68 | 1.43 | 2.33 | 1.86 | 1.60 | 1.36 |
| EV / EBITDA | 15.68 | 16.45 | 11.07 | 15.10 | 17.22 | 25.28 | 19.36 | 27.65 | 31.31 | 130.26 | 11.08 |
| EV / EBIT | 38.68 | 38.15 | 14.63 | 21.39 | 27.64 | 73.43 | 91.12 | 177.77 | — | — | 19.26 |
| EV / FCF | — | 19.14 | 8.84 | 26.47 | 13.98 | 14.27 | 15.51 | 22.21 | 53.12 | 100.63 | 10.33 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.2% | 76.2% | 77.0% | 76.1% | 76.8% | 77.1% | 73.3% | 70.7% | 70.7% | 66.2% | 67.6% |
| Operating Margin | 2.1% | 2.1% | 11.5% | 9.4% | 9.0% | 3.6% | 1.5% | 1.2% | -1.6% | -4.8% | 6.9% |
| Net Profit Margin | 1.1% | 1.1% | 8.1% | 6.3% | 7.0% | 6.1% | -4.8% | -0.5% | -2.8% | -3.9% | 3.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.1% | 4.1% | 28.9% | 22.0% | 22.7% | 19.6% | -13.3% | -1.3% | -7.1% | -8.0% | 6.4% |
| ROA | 1.2% | 1.2% | 9.2% | 7.0% | 7.2% | 6.0% | -4.4% | -0.5% | -2.8% | -3.6% | 3.6% |
| ROIC | 10.2% | 10.2% | 51.5% | 38.6% | 31.7% | 9.1% | 2.8% | 1.9% | -2.1% | -5.4% | 8.1% |
| ROCE | 6.2% | 6.2% | 34.2% | 26.4% | 21.7% | 7.5% | 2.7% | 2.2% | -2.7% | -6.7% | 9.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.12 | 0.12 | 0.07 | 0.19 | 0.29 | 0.41 | 0.62 | 0.48 | 0.56 | 0.55 | 0.41 |
| Debt / EBITDA | 0.56 | 0.56 | 0.13 | 0.39 | 0.64 | 1.38 | 2.50 | 2.06 | 3.63 | 20.33 | 1.57 |
| Net Debt / Equity | — | -0.36 | -0.51 | -0.29 | -0.44 | -0.18 | 0.16 | 0.14 | 0.44 | 0.44 | 0.30 |
| Net Debt / EBITDA | -1.70 | -1.70 | -0.94 | -0.59 | -0.95 | -0.61 | 0.65 | 0.59 | 2.82 | 16.41 | 1.14 |
| Debt / FCF | — | -1.98 | -0.75 | -1.03 | -0.77 | -0.35 | 0.52 | 0.48 | 4.78 | 12.68 | 1.07 |
| Interest Coverage | 10.74 | 10.74 | 30.53 | 17.34 | 14.17 | 3.89 | 1.34 | 1.25 | -1.06 | -3.53 | 6.26 |
Net cash position: cash ($32M) exceeds total debt ($8M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.82 | 0.82 | 0.99 | 0.96 | 1.01 | 1.00 | 0.99 | 1.15 | 1.06 | 1.14 | 1.66 |
| Quick Ratio | 0.79 | 0.79 | 0.96 | 0.93 | 0.99 | 0.98 | 0.96 | 1.12 | 1.02 | 1.10 | 1.57 |
| Cash Ratio | 0.20 | 0.20 | 0.30 | 0.25 | 0.39 | 0.35 | 0.26 | 0.27 | 0.11 | 0.11 | 0.19 |
| Asset Turnover | — | 1.10 | 1.10 | 1.14 | 1.01 | 0.90 | 0.97 | 1.00 | 0.98 | 0.88 | 1.05 |
| Inventory Turnover | 12.29 | 12.29 | 16.53 | 15.91 | 17.28 | 20.54 | 17.85 | 18.97 | 19.45 | 18.67 | 12.87 |
| Days Sales Outstanding | — | 93.50 | 109.29 | 106.61 | 100.76 | 115.08 | 103.74 | 118.60 | 125.45 | 131.22 | 123.87 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.1% | 1.2% | 4.3% | 2.9% | 2.7% | 2.2% | — | — | — | — | 2.9% |
| FCF Yield | 4.9% | 4.7% | 10.4% | 3.6% | 6.8% | 6.8% | 6.7% | 4.6% | 2.1% | 1.1% | 10.8% |
| Buyback Yield | 10.8% | 10.3% | 5.7% | 5.8% | 3.4% | 0.5% | 5.1% | 0.0% | 0.6% | 2.1% | 17.8% |
| Total Shareholder Yield | 10.8% | 10.3% | 5.7% | 5.8% | 3.4% | 0.5% | 5.1% | 0.0% | 0.6% | 2.1% | 17.8% |
| Shares Outstanding | — | $13M | $13M | $14M | $15M | $14M | $14M | $14M | $14M | $14M | $15M |
Operating margin compression
According to recent market data, Franklin Covey trades at a forward P/E of 66.24, a valuation that appears disconnected from the company's recent -7.02% revenue decline and the broader contraction in its core profitability metrics observed over the last ten quarters.
The current valuation suggests that investors are pricing in a significant turnaround or a return to high-growth SaaS-like scaling that the current financials do not support. Given the company's thin operating margins and recent negative earnings, the reliance on forward multiples warrants extreme caution as it assumes a rapid recovery in profitability that remains speculative.
Based on reported figures, Franklin Covey's ROIC has deteriorated from a peak of 31.9% in 2024Q4 to -1.2% in 2026Q2, signaling a sharp reversal in the company's ability to generate value from its invested capital base during this period of operational stress.
The collapse in return metrics suggests that the company's recent capital allocation, particularly aggressive share repurchases, has not been supported by underlying operational performance. Investors should monitor whether this decay is a temporary byproduct of the transition to subscription models or a structural decline in the efficacy of the firm's intellectual property investments.
As reported in financial statements, the company's cash conversion cycle has fluctuated significantly, reaching 78 days in 2026Q2, which reflects ongoing challenges in managing receivables and inventory relative to the firm's ability to leverage supplier payment terms effectively.
The elevated DSO, which remains near 82 days, indicates that the company may be facing difficulty in collecting payments from its corporate and education clients in a timely manner. This inefficiency in working capital management places additional pressure on liquidity, especially when combined with the company's recent operating losses.
Based on the company's quarterly filings, the current ratio has declined to 0.63, a level that indicates a tightening liquidity position and suggests that the firm may lack a sufficient buffer to absorb further operational volatility or unexpected seasonal funding gaps.
The deterioration of the quick ratio to 0.59 further highlights the company's reliance on future cash inflows to meet short-term obligations. This trend is particularly concerning given the recent contraction in deferred revenue, which serves as a primary indicator of future cash availability for the business.
As indicated by the company's financial profile, the market's tendency to apply pure-play SaaS valuation multiples to Franklin Covey obscures the high-touch, labor-intensive nature of its implementation services, which fundamentally limits the operating leverage achievable compared to traditional software firms.
Investors should prioritize 'Billings' and 'Deferred Revenue' growth over standard P/S or P/E multiples to better gauge the underlying health of the subscription business. Relying on software-like multiples ignores the reality that Franklin Covey's margins are structurally constrained by the high cost of professional consulting talent required to deliver its proprietary frameworks.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FC stock.
Franklin Covey Co.'s current P/E ratio is 90.4x. The historical average is 28.3x. This places it at the 100th percentile of its historical range.
Franklin Covey Co.'s current EV/EBITDA is 15.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.6x.
Franklin Covey Co.'s return on equity (ROE) is 4.1%. The historical average is 4.1%.
Based on historical data, Franklin Covey Co. is trading at a P/E of 90.4x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Franklin Covey Co. has 76.2% gross margin and 2.1% operating margin.
Franklin Covey Co.'s Debt/EBITDA ratio is 0.6x, indicating low leverage. A ratio below 2x is generally considered financially healthy.